Cited by 131Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Postsynaptic density proteins and their involvement in neurodevelopmental disorders

Kaizuka, Takeshi, Takumi, Toru·2018·The Journal of Biochemistry

Abstract

Synaptic connections are essential for neural circuits in order to convey brain functions. The postsynaptic density (PSD) is a huge protein complex associated with postsynaptic membranes of excitatory synapses. In mammals, the PSD is composed of more than 1,000 proteins including receptors, scaffold proteins, signalling enzymes and cytoskeletal proteins. PSD proteins are crucial for synaptic transmission and plasticity. Proteomic studies have revealed the composition of PSD proteins in various species, brain regions and specific physiological conditions. Abnormalities with PSD proteins are linked to various neuropsychiatric diseases including neurodevelopmental disorders such as autism spectrum disorder and schizophrenia. Here, we review different kinds of proteomic studies of the PSD and the involvement of PSD proteins in physiological and pathological conditions.

Overview

Integrity signals

Registry

Crossref · 10.1093/jb/mvy022

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 58

  1. Dosemeci, 2016, The postsynaptic density, there is more than meets the eye, Front. Synaptic Neurosci., 8, 23
  2. Zhu, 2016, Mechanistic basis of MAGUK-organized complexes in synaptic development and signalling, Nat. Rev. Neurosci., 17, 209
  3. Grant, 2012, Synaptopathies, diseases of the synaptome, Curr. Opin. Neurobiol., 22, 522
  4. Gratten, 2014, Large-scale genomics unveils the genetic architecture of psychiatric disorders, Nat. Neurosci., 17, 782
  5. Ryan, 2009, The origin and evolution of synapses, Nat. Rev. Neurosci., 10, 701
  6. Ting, 2012, Functional consequences of mutaions in postsynaptic scaffolding proteins and relevance to psychiatric disorders, Annu. Rev. Neurosci., 35, 49
  7. Frank, 2017, Supramolecular organization of NMDA receptors and the postsynaptic density, Curr. Opin. Neurobiol., 45, 139
  8. Monteiro, 2017, SHANK proteins, roles at the synapse and in autism spectrum disorder, Nat. Rev. Neurosci., 18, 147
  9. Carlin, 1980, Isolation and characterization of postsynaptic densities from various brain regions, enrichment of different types of postsynaptic densities, J. Cell Biol, 86, 831
  10. Peng, 2004, Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry, J. Biol. Chem., 279, 21003
  11. Li, 2004, Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology, J. Biol. Chem., 279, 987
  12. Yoshimura, 2003, Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry, J. Neurochem, 88, 759
  13. Jordan, 2004, Identification and verification of novel rodent postsynaptic density proteins, Mol. Cell. Proteomics, 3, 857
  14. Collins, 2006, Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome, J. Neurochem, 97(Suppl 1), 16
  15. Bayés, 2011, Characterization of the proteome, diseases and evolution of the human postsynaptic density, Nat. Neurosci., 14, 19
  16. Bayés, 2012, Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins, PLoS One, 7, e46683
  17. Bemben, 2015, The cellular and molecular landscape of neuroligins, Trends Neurosci, 38, 496
  18. Linhoff, 2009, An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers, Neuron, 61, 734
  19. Ethell, 2001, EphB/syndecan-2 signaling in dendritic spine morphogenesis, Neuron, 31, 1001
  20. Won, 2017, MAGUKs, multifaceted synaptic organizers, Curr. Opin. Neurobiol, 43, 94
  21. Irie, 1997, Binding of neuroligins to PSD-95, Science, 277, 1511
  22. Kim, 1997, GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules, J. Cell Biol., 136, 669
  23. Takeuchi, 1997, SAPAPs, J. Biol. Chem., 272, 11943
  24. Satoh, 1997, DAP-1, a novel protein that inteacts with the guanylate kinase-like domains of hDLG and PSD-95, Genes Cells, 2, 415
  25. Naisbitt, 1999, Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin, Neuron, 23, 569
  26. Tu, 1999, Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins, Neuron, 23, 583
  27. Hell, 2014, CaMKII, claiming center stage in postsynaptic function and organization, Neuron, 81, 249
  28. Okuno, 2012, Inverse synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1 with CaMKIIβ, Cell, 149, 886
  29. Heuberger, 2010, Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling, Cold Spring Harb. Perspect. Biol., 2, a002915
  30. Bian, 2015, Coordinated spine pruning and maturation mediated by inter-spine competition for cadherin/catenin complexes, Cell, 162, 808
  31. De Rubeis, 2011, Regulation of molecular pathways in the Fragile X Syndrome, insights into Autism Spectrum Disorders, J. Neurodevelop. Disord., 3, 257
  32. Frank, 2016, NMDA receptors are selectively partitioned into complexes and supercomplexes during synapse maturation, Nat. Commun., 7, 11264
  33. Husi, 2000, Proteomic analysis of NMDA receptor-adhesion protein signaling complexes, Nat. Neurosci., 3, 661
  34. Bayés, 2014, Human post-mortem synapse proteome integrity screening for proteomic studies of postsynaptic complexes, Mol. Brain, 7, 88
  35. Schwenk, 2012, High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes, Neuron, 74, 621
  36. Fernández, 2009, Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins, Mol. Syst. Biol., 5, 269
  37. Dosemeci, 2007, Composition of the synaptic PSD-95 complex, Mol. Cell. Proteomics, 6, 1749
  38. Farr, 2004, Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents, J. Neurochem., 91, 438
  39. Pandya, 2016, Group 1 metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex, Proteomics., 16, 2698
  40. Li, 2017, Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders, Nat. Neurosci., 20, 1150
  41. Emes, 2008, Evolutionary expansion and anatomical specialization of synapse proteome complexity, Nat. Neurosci., 11, 799
  42. Bayés, 2017, Evolution of complexity in the zebrafish synapse proteome, Nat. Commun, 8, 14613
  43. Coba, 2009, Neurotransmitters drive combinatorial multistate postsynaptic density networks, Sci. Signal, 2, ra19
  44. Li, 2016, Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome, Sci. Signal, 9, rs8
  45. Föcking, 2015, Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia, Mol. Psychiatry, 20, 424
  46. Föcking, 2016, Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder, Transl. Psychiatry, 6, e959
  47. Zhou, 2013, Proteomic analysis of postsynaptic density in Alzheimer's disease, Clin. Chim. Acta, 420, 62
  48. Liu, 2014, Genomic and genetic aspects of autism spectrum disorder, Biochem. Biophys. Res. Commun, 452, 244
  49. de la Torre-Ubieta, 2016, Advancing the understanding of autism disease mechanisms through genetics, Nat. Med., 22, 345
  50. Takumi, 2018, CNV biology in neurodevelopmental disorders, Curr Opin Neurobiol, 48, 183
  51. Nakanishi, 2017, Functional significance of rare neuroligin 1 variants found in autism, PLoS Genet., 13, e1006940
  52. Kazdoba, 2016, Behavioral phenotypes of genetic mouse models of autism, Genes Brain Behav, 15, 7
  53. Wang, 2017, Distinct defects in spine formation or pruning in two gene duplication mouse models of autism, Neurosci. Bull., 33, 143
  54. Owen, 2016, Schizophrenia, Lancet, 388, 86
  55. Hayashi-Takagi, 2017, Synapse pathology and translational applications for schizophrenia, Neurosci. Res., 114, 3
  56. Palay, 1956, Synapses in the central nervous system, J. Biophys. Biochem. Cytol., 2, 193
  57. King, 2011, Is schizophrenia on the autism spectrum?, Brain Res., 1380, 34
  58. Ignatchenko, 2015, VennDIS: a JavaFX-based Venn and Euler diagram software to generate publication quality figures, Proteomics., 15, 1239

Cited by

Sorted by citations

See all 131

Metadata

Authors
Kaizuka, T., & Takumi, T.
Affiliations
RIKEN Center for Brain Science (JP)
Corresponding author
Takumi, Toru
Venue
The Journal of Biochemistry
Published
2018-02-05
Volume
163
Issue
6
Pages
447-455
ISSN
  • 0021-924X (ISSN-L)
  • 1756-2651
OpenAlex
W2792126067
Cited by
131
References
0
Citations by year
2026: 9 · 2025: 18 · 2024: 24 · 2023: 12 · 2022: 22 · 2021: 19 · 2020: 14 · 2019: 10 · 2018: 3
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • JSPS
  • Ministry of Education, Culture, Sports, Science and Technology
  • Takeda Science Foundation
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
postsynaptic density, postsynaptic density proteins, neurodevelopmental disorders, autism spectrum disorder, schizophrenia, synaptic transmission, synaptic plasticity, excitatory synapses, neuropsychiatric disorders
MeSH terms
Animals, Humans, Nerve Tissue Proteins, Proteomics, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review